Vitale, Felice Vito <br/><br/>
Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.  [electronic resource] 

 -  Anticancer research   
 - 4077-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Combined Modality Therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Immunotherapy--methods<br/>Infusions, Intra-Arterial<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Recombinant Proteins